|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 16, 2017 ) About Pulmonary Arterial Hypertension (PAH) Drugs
PAH in the arteries, which carry blood from the heart to the lungs, occurs when blood vessels become narrow, making blood flow difficult.
Publisher's analysts forecast the global pulmonary arterial hypertension drugs market to grow at a CAGR of 3.2% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-pulmonary-arterial-hypertension-pah-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global pulmonary arterial hypertension drugs market for 2017-2021. To calculate the market size, the report considers the MoA and the RoA.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Pulmonary Arterial Hypertension Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Actelion Pharmaceuticals
- DAIICHI SANKYO
- GlaxoSmithKline
- Novartis
- United Therapeutics
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001723471/sample .
Other prominent vendors
- AADi
- Actelion Pharmaceuticals
- Aires Pharmaceuticals
- Arena Pharmaceuticals
- Asklepion Pharmaceuticals
- AstraZeneca
- Bayer Healthcare
- Berlin Cures
- BIAL
- DEKA Research & Development
- Dong- A ST
- Eiger BioPharmaceuticals
- Gilead Sciences
- Lung Biotechnology
- Merck
- Northern Therapeutics
- Pfizer
- PhaseBio Pharmaceuticals
- Radikal Therapeutics
- Reata Pharmaceuticals
- SteadyMed Therapeutics
- Velo Bio
Market driver
- New disease-modifying therapies
- For a full, detailed list, view our report
Market challenge
- Patent expiries of major drugs
- For a full, detailed list, view our report
Market trend
- Increased focus on combination therapies
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001723471/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
